Get started
Author

Marianne E. Jauncey

Observed names: Jauncey, Marianne, Jauncey, Marianne E, M JAUNCEY, M. JAUNCEY, M. Jauncey, MARIANNE JAUNCEY, Marianne E Jauncey, Marianne Jauncey, Marianne Jauncey (13581640)
Institution: Uniting
Observed institutions: The University of Sydney, New South Wales Department of Health, Curtin University, Government of New South Wales, UNSW Sydney, South Eastern Sydney Local Health District, Hunter New England Local Health District, Uniting, National Drug and Alcohol Research Centre, National Drug Research Institute, Monash University, University of Newcastle Australia
ORCID: 0000-0001-9712-5579
Observed ORCID: 0000-0001-9712-5579
OpenAlex ID: A5018800869
High incidence of hepatitis C virus reinfection within a cohort of injecting drug users
2006 · J. M. Micallef, V. Macdonald, et al. · Journal of Viral Hepatitis · 110
Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users
2008 · R. Dwyer, L. Topp, et al. · Drug and Alcohol Dependence · 92
Injecting-related injury and disease among clients of a supervised injecting facility
2009 · Allison M. Salmon, Robyn Dwyer, et al. · Drug and Alcohol Dependence · 78
Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial
2019 · Paul Dietze, Marianne Jauncey, et al. · JAMA Network Open · 72
PDF
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study
2015 · A.D. Marshall, M. Micallef, et al. · International Journal of Drug Policy · 65
Clearance of Hepatitis C Virus after Newly Acquired Infection in Injection Drug Users
2004 · Marianne Jauncey, Joanne M. Micallef, et al. · The Journal of Infectious Diseases · 65
Strategies and outcomes in translating alcohol harm reduction research into practice: the Alcohol Linking Program
2004 · JOHN WIGGERS, MARIANNE JAUNCEY, et al. · Drug and Alcohol Review · 54
An overview of take‐home naloxone programs in Australia
2018 · Robyn Dwyer, Anna Olsen, et al. · Drug and Alcohol Review · 52
PDF
Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia
2021 · Amanda Roxburgh, Marianne Jauncey, et al. · Harm Reduction Journal · 51
Drug consumption rooms: A systematic review of evaluation methodologies
2019 · Vendula Belackova, Allison M. Salmon, et al. · Drug and Alcohol Review · 44
Australia reschedules naloxone for opioid overdose
2016 · Simon R Lenton, Paul M Dietze, et al. · The Medical Journal of Australia · 34
Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre
2016 · Julie Latimer, Stephen Ling, et al. · International Journal of Drug Policy · 32
Drug consumption rooms (DCRs) as a setting to address hepatitis C – findings from an international online survey
2018 · Vendula Belackova, Allison M. Salmon, et al. · Hepatology Medicine and Policy · 31
PDF
Broadening discussions of “safe” in hepatitis C prevention: A close-up of swabbing in an analysis of video recordings of injecting practice
2007 · Carla Treloar, Becky Laybutt, et al. · International Journal of Drug Policy · 31
Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre
2017 · Amanda Roxburgh, Shane Darke, et al. · Drug and Alcohol Dependence · 29
Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users
2006 · J. AMIN, M. G. LAW, et al. · Epidemiology and Infection · 28
PDF
Designing, implementing and evaluating the overdose response with take‐home naloxone model of care: An evaluation of client outcomes and perspectives
2019 · Nicholas Lintzeris, Lauren A. Monds, et al. · Drug and Alcohol Review · 22
PDF
Twenty‐one years at the Uniting Medically Supervised Injecting Centre, Sydney: addressing the remaining questions
2022 · Carolyn A Day, Allison Salmon, et al. · The Medical Journal of Australia · 20
PDF
Mental health among clients of the Sydney Medically Supervised Injecting Centre (MSIC)
2016 · Mark Goodhew, Allison M. Salmon, et al. · Harm Reduction Journal · 20
PDF
The definition of opioid‐related deaths in Australia: implications for surveillance and policy
2005 · MARIANNE E. JAUNCEY, LEE K. TAYLOR, et al. · Drug and Alcohol Review · 20
Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type
2020 · Elodie Lefrancois, Vendula Belackova, et al. · Drug and Alcohol Dependence · 19
PDF
Infrequent detection of unintentional fentanyl use via urinalysis among people who regularly inject opioids in Sydney and Melbourne, Australia
2022 · Tina Lam, Monica J. Barratt, et al. · Addiction · 18
PDF
Urine drug screening for early detection of unwitting use of fentanyl and its analogues among people who inject heroin in Sydney, Australia
2018 · Monica J. Barratt, Julie Latimer, et al. · Drug and Alcohol Review · 18
PDF
Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops
2023 · Suzanne Nielsen, Monica Barratt, et al. · International Journal of Drug Policy · 17
The impact of OxyContin reformulation at the Sydney Medically Supervised Injecting Centre: Pros and cons
2017 · Marianne Jauncey, Michael Livingston, et al. · International Journal of Drug Policy · 14
Works count: 67
Citation count: 1,182
H-index: 20
I10-index: 27
Year
Topic
Type